GENEURO Aktie

>GENEURO Performance

1 Woche: 0%

1 Monat: 0%

3 Monate: +2,3%

6 Monate: -32,7%

1 Jahr: -50,7%

laufendes Jahr: -10,7%

>GENEURO Aktie

Name:

GENEURO SA SF-,05

Land:

Schweiz

Sektor:

Gesundheit

ISIN/ Wkn:

CH0308403085 / A2AHDP

Symbol/ Ticker:

GEM (Frankfurt)

Kürzel:

FRA:GEM, ETR:GEM, GEM:GR

Index:

Webseite:

http://www.geneuro.ch/

Profil:

GeNeuro SA is a Swiss-based clinical-stage biopharmaceutical company specializing in the development of monoclonal antibodies to neutralize pathogenic proteins from human endogenous retroviruses (HERVs) implicated in neurodegenerative and autoimmune ..
>Volltext..

Marktkapitalisierung:

0.91 Mio. EUR

Unternehmenswert:

Umsatz:

EBITDA:

Nettogewinn:

Gewinn je Aktie:

Schulden:

Liquide Mittel:

Operativer Cashflow:

Bargeldquote:

Umsatzwachstum:

Gewinnwachstum:

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

GENEURO

Letzte Datenerhebung:

06.04.26

>GENEURO Kennzahlen

Aktien/ Unternehmen:

Aktien: 29.49 Mio. St.

Frei handelbar: 80.68%

Leerverk. Aktien: -

Rückkaufquote: -

Mitarbeiter: -

Umsatz/Mitarb.: -

Analysten:

Analystenrating: No rating

Kursziel: -

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: -

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -

Eigenkaprendite: -

>GENEURO Peer Group

Gesundheit, Multiple Sklerose- Behandlung, Neurologische- & psychische Behandlung/ Medizin, Autoimmunerkrankungen, Covid 19- Behandlung/ post Covid/ long Covid

>GENEURO Chart & Kurs - Frankfurt
- Boerse Frankfurt
- >Profi Charts

>GENEURO News

19.02.26 - 20:39	XFRA: Correction - Deletion of Instruments from Boerse Frankfurt - 19.02.2026 (XETRA)
	The following instrument will not be delisted from Boerse Frankfurt: Das folgenden Instrument bleibt weiterhin handelbar auf Boerse Frankfurt: ISIN Name CH0308403085 GENEURO SA SF-,05...

19.02.26 - 20:24

XFRA: Deletion of Instruments from Boerse Frankfurt - 19.02.2026 (XETRA)

The following instruments on Boerse Frankfurt do have their last trading day on 19.02.2026 Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 19.02.2026 ISIN Name AU0000416109 RYZON MATERIALS LTD. CA11120Q3026 BRIXTON METALS CORP. CA30219M1059 EXPLOITS DISCOVERY CORP. CA30321D2095 FABLED COPPER CORP. CA7270532095 PLANET VENTURES CA86084H4070 STI.GRP.INC. O.N. CH0308403085 GENEURO SA SF-,05 ES0105376000 ARIMA REAL EST.SOC. EO 1 FR0013335742 COGELEC S.A. EO-,45...

23.01.26 - 10:31	XFRA: GEM: Aussetzung/Suspension (XETRA)
	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL GENEURO SA SF-,05 GEM CH0308403085 BAW/UFN...

23.01.26 - 10:31	XFRA: INSTRUMENT_SUSPENSION - CH0308403085 (XETRA)
	Instrument ID [2268] (GEM - CH0308403085) suspended...

15.10.25 - 20:27

GeNeuro SA Postpones Publication of June 30, 2025 Half-Yearly Financial Report (Business Wire)

GENEVA--(BUSINESS WIRE)--Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases, announces the postponement of its June 30, 2025 half-yearly results and half-yearly financial report. This decision is in line with the postponement of the annual results for the fiscal year ended December 31, 2024, annual results and annual financial report in order to be able to take into account the financial impacts of the restructuring targeted by the Company as part of the debt-restructuring moratorium procedure extended on September 25, 2025. The Company will announce by press release the new date of their approval and publication. About GeNeuro GeNeuro's mission is to develop safe and effective treatments against neurological disorders and autoimmune diseases, such as multiple sclerosis, by neutralizing causal factors encoded by HERVs, which represent 8% of human DNA. GeNeuro is based in Geneva. About the debt...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Das sind halt die Freuden eines Preisministers, wenn ab und zu nicht alles teurer wird. - Dr. Josef Staribacher

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram